FDA Maharashtra seizes drugs worth Rs 61.95 lakh

FDA Maharashtra officials revealed that Urbancare Lifesciences LLP had repeatedly neglected its legal obligation to inform the change in constitution.

394
FDA Maharashtra seizes drugs worth Rs 61.95 lakh
FDA Maharashtra seizes drugs worth Rs 61.95 lakh

Last Updated on April 20, 2025 by The Health Master

FDA Maharashtra

The Food and Drug Administration, Maharashtra (FDA Maharashtra), conducted a successful raid at a wholesale drug distributor located in Ghatkopar, Mumbai, and seized a huge stock of drugs worth ₹61.95 lakh.

These drugs were seized from Urbancare Lifesciences LLP, which had allegedly been operating without a valid license for over a year and a half by not complying with the important rules and regulations laid down under the Drugs and Cosmetics Act of 1940.

Repeated Non-Compliance with Ownership Change Rules

FDA Maharashtra officials revealed that Urbancare Lifesciences LLP had repeatedly neglected its legal obligation to inform the agency about alterations in its ownership structure.

As per the established guidelines, any changes in the constitution of a licensed entity necessitate a notification to the FDA of the relevant state and a subsequent application for a renewed license within 90 days of the change.

According to the FDA Maharashtra’s records, Urbancare Lifesciences underwent partnership changes on three separate occasions between 2021 and 2024, with the most recent alteration occurring in May.

Officials emphasized that the initial license, granted in 2021, became void following the very first change in the company’s partnership.

Quick Enforcement Action

The raid was conducted on the directions of FDA Maharashtra commissioner Rajesh Narvekar and under the supervision of senior officers from the vigilance wing as well as from Greater Mumbai divisions of FDA Maharashtra.

Consequences and Future Course of Action

At the time of reporting, representatives of Urbancare Lifesciences LLP could not be reached for comment.

FDA Maharashtra officers stated, “While they informed the GST office, they failed to do the same with the FDA Maharashtra.”

“They will have to re-apply for a license now to start operations again.”

This indicates a potentially lengthy legal process for the company, with the seized stock remaining under FDA Maharashtra control pending court directives.

Q. What action did the FDA Maharashtra take against the unlicensed distributor?

A. The FDA Maharashtra has taken action against Urbancare Lifesciences LLP, a wholesale drug distributor in Ghatkopar, and seized a huge stock worth ₹61.95 lakh.

Q. Why was the raid conducted by FDA Maharashtra?

A. The company was operating without a valid license for over a year and a half and repeatedly failed to notify the FDA Maharashtra of changes in its ownership structure, as required under the Drugs and Cosmetics Act of 1940.

Q. What is the legal requirement regarding changes in ownership for a license holder under the Drugs and Cosmetics Act?

A. A firm holding a license under the Drugs and Cosmetics Act is legally required to inform the concerned FDA office of the state and apply for a license within 90 days of any change in their constitution (ownership structure).

Disclaimer: This article contains information obtained from the source mentioned below. Our team made changes in the format to rewrite and present the news or article in a unique format.

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news